Inventiva to Attend Four Upcoming Investor Conferences in March

Inventiva, a clinical-stage biopharmaceutical company, will participate in four upcoming investor conferences in March, including the TD Cowen 46th Annual Health Care Conference, Leerink Global Healthcare Conference, Barclays 28th Annual Global Healthcare Conference, and UBS Biotech Conference. The Company's leadership will hold one-on-one meetings and presentations during these events, with webcasts available on their website. Inventiva is focused on developing an oral therapy for metabolic dysfunction-associated steatohepatitis (MASH).